271 related articles for article (PubMed ID: 26543366)
1. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N
Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366
[TBL] [Abstract][Full Text] [Related]
2. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.
Mohsen AM; Asfour MH; Salama AAA
Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
4. Formulation design and characterization of silymarin liposomes for enhanced antitumor activity.
Ke Z; Cheng X; Yang H; Niu Y; Cheng X; Ye T; Sun G; Cheng Z; Sun Y
Pak J Pharm Sci; 2024 Jan; 37(1):139-145. PubMed ID: 38741410
[TBL] [Abstract][Full Text] [Related]
5. Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: Preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Fan Q; Zhang Y; Hou X; Li Z; Zhang K; Shao Q; Feng N
Int J Pharm; 2018 Dec; 552(1-2):360-370. PubMed ID: 30292894
[TBL] [Abstract][Full Text] [Related]
6. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R
J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
Xiao YY; Song YM; Chen ZP; Ping QN
Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
[TBL] [Abstract][Full Text] [Related]
8. A comparative study on the preparation and evaluation of solubilizing systems for silymarin.
Chen Z; Gao W; Feng X; Zhou G; Zhang M; Zeng L; Hu X; Liu Z; Song H
Drug Deliv Transl Res; 2024 Jun; 14(6):1616-1634. PubMed ID: 37964172
[TBL] [Abstract][Full Text] [Related]
9. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
10. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel.
Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D
Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
[TBL] [Abstract][Full Text] [Related]
12. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
[TBL] [Abstract][Full Text] [Related]
13. A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.
Wang M; Xie T; Chang Z; Wang L; Xie X; Kou Y; Xu H; Gao X
PLoS One; 2015; 10(12):e0143625. PubMed ID: 26674103
[TBL] [Abstract][Full Text] [Related]
14. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.
Shangguan M; Lu Y; Qi J; Han J; Tian Z; Xie Y; Hu F; Yuan H; Wu W
J Biomater Appl; 2014 Feb; 28(6):887-96. PubMed ID: 24008629
[TBL] [Abstract][Full Text] [Related]
15. Stability and aerodynamic behaviour of glucocorticoid particles prepared by a supercritical fluids process.
Velaga SP; Bergh S; Carlfors J
Eur J Pharm Sci; 2004 Mar; 21(4):501-9. PubMed ID: 14998581
[TBL] [Abstract][Full Text] [Related]
16. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Int J Pharm; 2008 Jul; 359(1-2):35-45. PubMed ID: 18440736
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.
Shangguan M; Qi J; Lu Y; Wu W
Int J Pharm; 2015 Jul; 489(1-2):195-202. PubMed ID: 25956049
[TBL] [Abstract][Full Text] [Related]
18. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
El-Samaligy MS; Afifi NN; Mahmoud EA
Int J Pharm; 2006 Feb; 308(1-2):140-8. PubMed ID: 16356669
[TBL] [Abstract][Full Text] [Related]
19. Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization.
Richardson CH; de Matas M; Hosker H; Mukherjee R; Wong I; Chrystyn H
Pharm Res; 2007 Nov; 24(11):2008-17. PubMed ID: 17510755
[TBL] [Abstract][Full Text] [Related]
20. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
